NEWNAN, Ga., Oct. 30-- CeloNova BioSciences today announced that the company is submitting to its European Notified Body a request for approval of its new, lime green, 2800 micron size Embozene™ ...

PALO ALTO, Calif., September 09, 2025--(BUSINESS WIRE)--Varian, a Siemens Healthineers company, announced today that its Embozene microspheres have received CE Marking for Genicular Artery ...

NEWNAN, Ga., Dec. 16 CeloNova BioSciences, Inc., announcedtoday that it has received 510(k) marketing clearance from the U.S. Food andDrug Administration (FDA) for Embozene(TM) Color-Advanced ...

PALO ALTO, Calif., Nov. 17, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the first trial participant has been treated as part of GENESIS II (Genicular artEry ...

Varian, a Siemens Healthineers company, announced that the US Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its Embozene microspheres for genicular ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. CeloNova BioSciences won FDA approval for a new treatment ...

SAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences, Inc. (CeloNova), today announced that the U.S. Food and Drug Administration (FDA) has granted approval to start an investigational device exemption ...

In an attempt to bolster its footprint in the burgeoning interventional oncology space, medical device major Boston Scientific Corporation BSX recently agreed to purchase the interventional radiology ...

Varian, a Siemens Healthineers company, announced today that its Embozene microspheres have received CE Marking for Genicular Artery Embolisation (GAE) for knee osteoarthritis. This regulatory ...